| 1 | Adam Chu | Romeo Blanc | Integrative Nascent Transcriptomics and Epigenomic Profiling of Pol II Pausing in Muscle Stem Cells | Quiescent stem cells must retain the capacity for rapid activation without triggering premature transcription, yet how chromatin encodes this latent potential remains incompletely understood. We developed a transformer-based model that predicts gene expression from histone mark profiles, using cross-mark attention and systematic prediction failure as tools for biological discovery. Trained on 15 histone marks across a 7 kb promoter-to-gene-body window in K562 cells, the model achieves strong predictive performance (test Pearson r = 0.86) and, through in-silico knockout and attribution analyses, identifies H3K36me3 and H3K79me2 gene-body signal as the dominant and most reproducible determinants of expression, a co-transcriptional elongation signature that outweighs canonical promoter marks such as H3K4me3. Applying this model across cell types, we found that in quiescent muscle stem cells, Rb/E2F cell-cycle target genes retain H3K4me3 at silent promoters, causing systematic model over-prediction. This “poised” signature is conserved across four germ-layer-distinct quiescent stem cell populations and stable across aging, nominating specific loci and mark combinations for direct experimental interrogation. To validate whether these poised promoters are genuinely monovalent at single-molecule resolution, we are developing CoCUT&Tag, a method for simultaneous two-mark profiling with direct co-occupancy readout at single-cell resolution. Building on model-derived predictions of causally necessary chromatin marks, we further propose using dCas9-KDM5 fusions to remove H3K4me3 at targeted promoters in quiescent cells and test its requirement for rapid reactivation. Together, this predict-verify-perturb framework links model-driven discovery, single-molecule validation, and direct epigenome editing to dissect the causal architecture of stem cell quiescence. |
| 2 | Hannah Hwang | Romeo Blanc | Promoter-proximal pausing establishes bioenergetic readiness in quiescent muscle stem cells | Skeletal muscle regeneration relies on a rare population of muscle stem cells (MuSCs), which preserve their regenerative capacity by entering quiescence, a reversible state of growth arrest. These quiescent muscle stem cells face a fundamental paradox: transcription must remain restrained to maintain quiescence, yet gene expression must be rapidly activated upon injury. However, the mechanisms that enable this balance remained poorly understood. Here, we show that quiescence represents a state of strategic pause, in which transcriptional pausing maintains genes in readiness for rapid activation following injury. Using Precision Run-On sequencing (PRO-seq), we found that quiescent MuSCs exhibit widespread genome-wide promoter-proximal transcriptional pausing, which is broadly released upon activation. Gene Ontology analysis of paused genes revealed strong enrichment for mitochondrial pathways. Remarkably, ranking mitochondrial genes by pausing index showed that nearly 80% fall into a transcriptionally poised category, suggesting that energy production programs are strategically restrained in quiescence. Transcription factor enrichment analysis identified the YY1 as the top predicted regulator of these paused gene set. Consistent with this, CUT&Tag profiling revealed that these paused genes carry a dual epigenetic signature of H4K20me1 and H4K16ac in quiescence, with selective loss of H4K16ac upon activation. These findings suggest that dynamic histone modifications cooperate with transcriptional regulators to stabilize promoter-proximal pausing at metabolic genes. Together, our findings uncover a previously unrecognized regulatory layer in which quiescent MuSCs selectively enforce transcriptional pausing at mitochondrial gene programs to enable a rapid surge of energy production upon activation. These findings reveal a regulatory mechanism that preserves metabolic readiness in quiescent MuSCs and suggest new avenues for enhancing muscle regeneration in aging and degenerative muscle diseases. |
| 3 | Sidra Jabeen | Jeff Dilworth | Muscle stem cell-derived high molecular weight hyaluronan attenuates dystrophic pathology in mdx mice | Muscle stem cell-derived high molecular weight hyaluronan attenuates dystrophic pathology in mdx mice Duchenne muscular dystrophy (DMD) is characterized by chronic muscle degeneration and persistent inflammation that progressively impair tissue repair. Muscle stem cells (MuSCs) both regenerate damaged muscle and contribute to the extracellular matrix that shapes the regenerative niche. We previously demonstrated that loss of MuSC-derived HAS2 amplifies inflammatory cytokine production following injury, identifying hyaluronic acid as a regulator of the regenerative microenvironment. We therefore asked whether sustained MuSC-derived HMW-HA production could modify disease progression in dystrophic muscle. To this end we generated tamoxifen-inducible mice with MuSC-specific constitutive HMW-HA production in an mdx background, a mouse model of DMD. MuSC-specific overexpression of HMW-HA increased normalized grip strength by 47% relative to mdx controls beginning at 8 weeks of age, with this functional benefit sustained through 24 weeks. Histological analyses at 8 and 12 weeks revealed fewer centrally nucleated fibers (a hallmark of ongoing dystrophic pathology), despite no differences in body weight or hindlimb muscle mass. MuSC-specific HMW-HA overproduction also altered the characteristic bimodal fiber size distribution of dystrophic muscle, eliminating the enlarged-fiber population observed in mdx mice. FACS analyses demonstrated a 20% reduction in CD11b+/CD45+ inflammatory cell infiltration in dystrophic muscle. Remarkably, these improvements were achieved by selectively modifying the extracellular matrix produced by MuSCs, despite these cells comprising only a small fraction of skeletal muscle. Together, these findings demonstrate that selectively enhancing extracellular matrix production by MuSCs is sufficient to reshape disease pathology at functional, histological, and cellular levels. These findings establish extracellular matrix engineering of tissue stem cells as a potential strategy for modifying diseased microenvironments and may inform regenerative therapies across conditions where stem cell function is compromised. Furthermore, our results suggest stem cells are not only regenerative cells but also architects of the regenerative microenvironment. |
| 4 | Rachel Walkup | Robert Lipinski | Environmental Modulation of DNA Methylation in Orofacial Cleft Risk | Orofacial clefts (OFCs) are among the most common structural birth defects, yet prevention strategies remain limited due to an incomplete understanding of environmental risk factors and their mechanisms. Epidemiological studies link periconceptual intake of folic acid, a dietary methyl-donor, to reduced OFC risk, but direct experimental evidence is limited, and the molecular mechanisms underlying this association remain unclear. We previously demonstrated that disruption of DNA methylation is sufficient to induce OFCs, therefore we hypothesize that environmental modulation of DNA methylation influences OFC risk through altered gene regulation during craniofacial morphogenesis. To test this, we performed tandem whole-genome methylation and bulk RNA sequencing on gestational day (GD) 11 facial growth centers that form the upper lip and primary palate in C57BL/6J mice exposed to either a control (3 mg/kg diet) or supplemented (20 mg/kg diet) maternal folic acid diet. Folic acid supplementation induced global DNA hypermethylation and altered expression of genes involved in skeletal development, WNT signaling, and cell fate commitment. Additionally, in a mouse model of incompletely penetrant OFCs caused by disrupted SHH signaling, prenatal folic acid supplementation significantly reduced OFC severity, as measured by morphometric analysis of facial growth center outgrowth and nostril width. In contrast, prenatal exposure to cadmium, which is known to disrupt enzymes involved in DNA methylation regulation, induced cleft palate and forelimb malformations and was associated with global hypermethylation in the palatal maxillary process. Together, these findings demonstrate that prenatal environmental exposures modulate OFC risk with dietary methyl donor supplementation mitigating and heavy metal exposure exacerbating craniofacial malformations. This work identifies DNA methylation as a mechanistic link between environmental exposures and OFC risk to support the development of mechanism-based prevention measures. |
| 5 | Alex Fister | Anna Huttenlocher | Understanding changes in microglia responsivity in aging and Alzheimer’s Disease via PLCG2-mediated signaling | Microglia are the resident innate immune cells of the central nervous system responsible for maintenance of brain health and homeostasis. During the aging process, microglia can become dystrophic, resulting in impairment of their basic brain maintenance functions and instead fueling neuroinflammation. Chronic neuroinflammation contributes to neurological diseases of aging, such as Alzheimer’s Disease (AD), as well as cognitive decline in normal aging. Recent studies have shown that most genes associated with differential risk of developing AD are primarily expressed by microglia. However, the mechanisms that drive these differential dystrophic or protective microglial responses are not well understood. One such gene identified in these studies is PLCG2, a member of the phospholipase C family. Both hypermorphic, AD-protective (P522R) and hypomorphic, AD-risk-conferring (M28L) variants have been identified, but it is still unclear how they control microglial responsiveness. Previous studies have found that these variants affect how immune cells migrate and interact with their surrounding environment, a process known to be driven by polarized actin assembly. To test whether PLCG2 mutations result in differential utilization of actin assembly pathways during microglial response to normal developmental stimuli, I will take advantage of the developing zebrafish brain. During development, microglia take part in widespread efferocytosis of apoptotic neurons and synapse pruning. This process can be easily visualized in zebrafish larva. I will first make zebrafish hyper- and hypomorphic PLCG2 mutants that have microglia transgenically labeled with lifeact to visualize actin content/dynamics and measure migration speed. Additionally, to characterize these differences compared to young microglia, I will test their actin content in the developing zebrafish brain and use acridine orange to stain apoptotic neurons to visualize efferocytosis. Collectively, these experiments will further our mechanistic understanding of microglia responsivity throughout aging. |
| 6 | Zhili Chen | Anna Huttenlocher | CD163 labels an activated subpopulation of human neutrophils | CD163 labels an activated subpopulation of human neutrophils Neutrophils are the first defender of the innate immune response. However, their short half-life has made them challenging to study. Human induced pluripotent stem cell (iPSC)-derived neutrophils (iNeutrophils) provide an option for the stable generation of neutrophils. Prior work showed that knocking out transcription factor GATA1 (GATA1-KO) increases the antifungal activity of iNeutrophils. However, how GATA1-KO iNeutrophils have improved function is yet to be understood. We found that GATA1-KO iNeutrophils exhibit enhanced degranulation compared with wild-type (WT) iNeutrophils. To understand this, we performed scRNA-seq and identified a distinct CD163 expressing subpopulation that was enriched in GATA1-KO iNeutrophils, validated by flow cytometry. We isolated CD163+/- GATA1-KO iNeutrophils and found that CD163+ population had enhanced degranulation compared to the CD163- population. CD163 is known in macrophages, however a function in neutrophils has not been described. We found that CD163 is present on primary human neutrophils (PMN), and its surface expression is significantly increased with stimulation. The CD163+ subpopulation expressed significantly higher neutrophil activation marker than CD163- subpopulation, and PMN’s ability to secrete MPO dampened after treatment with CD163 neutralizing antibody. Using iNeutrophils as a tool, we identified a new marker for primary human neutrophil activation, that potentially represents a future therapeutic target. |
| 7 | Jade Elliott | Igor Slukvin | Improving Skin Cell to Blood Cell Engraftment using scRNA Sequencing and Non-Human Primates | Induced pluripotent stem cell-derived hematopoietic stem cells (iHSCs) hold immense clinical potential for cell-based therapies, yet current differentiation systems are still inferior in engraftment potential compared to bone marrow and peripheral blood mobilized HSCs. Additionally, these in vivo-derived HSCs significantly improve clinical engraftment outcomes by reducing the duration of cytopenia following myeloablation. We hypothesize that our iHSCs are more similar to fetal HSCs when they are first formed in the embryo. To test this hypothesis, we compiled over a hundred single-cell RNA-seq hematopoietic datasets in primates spanning the first emergence of HSCs in the embryo to their establishment in the fetal bone marrow. We then integrated this “fetal primate HSC transcriptomic atlas” with our in vitro-derived iHSCs to identify what time point our iHSCs more closely resemble and what markers are lacking to improve the transcriptomic phenotype of our iHSCs. |
| 8 | Yuju Jun | Igor Slukvin | Enhanced Targeting of Solid Tumors with iPSC-Derived CAR Neutrophils via Genetic Ablation of the SIRPa-CD47 Pathway | While tumor-associated neutrophils (TANs) have long been considered a pro-tumor agent in the tumor microenvironment (TME), recent studies show that chimeric antigen receptor (CAR) engineering reprograms TANs to have antitumor activities. However, short lifespan and lack of persistence of CAR neutrophils continue to challenge their clinical applications to targeted immunotherapies. Here, we demonstrate that ablation of the SIRPa-CD47 “Don’t eat me” axis in CAR iPSC-derived CAR neutrophils (CAR iNeuts) enhances their antitumor activity against CD47-expressing tumors without exogenous monoclonal antibody (mAb) administration. We also circumvent the genetic intractability of neutrophils by knocking out SIRPa at the CAR-expressing induced pluripotent stem cells (CAR-iPSCs) level and establish a reproducible protocol to differentiate them into functional neutrophils. These CAR/SIRPa-/- iNeuts express higher levels of mature neutrophil markers than CAR iNeuts and inhibit tumor growth more efficiently both in short and long term. Compared to CAR iNeuts, CAR/SIRPa-/- iNeuts exhibited more rapid and sustained antitumor effects after serial tumor exposures to show the critical role of SIRPa in regulating the persistence and exhaustion of neutrophils. These findings highlight CAR/SIRPa-/- iNeuts as a potent antitumorigenic agent in the TME and provide a noble insight into the therapeutic application of TANs. |
| 9 | Mireya Pimentel | Matthew Brown | Derivation of Human Thymic-Derived Induced Pluripotent Stem Cells for Modeling and Therapeutic Development Studies | Neonatal thymus tissue is routinely removed and discarded during corrective surgery for congenital heart defects, representing a unique opportunity to generate patient-specific induced pluripotent stem cells (iPSCs) for future regenerative therapies. Here, we established iPSC lines from two distinct thymic cell populations, developing T cells (thymocytes) and thymic fibroblasts (T-fibs), to create a donor-specific platform for cellular therapy development. Human thymocytes and thymic fibroblasts isolated from pediatric thymus tissue were reprogrammed using Sendai virus-mediated delivery of OCT4, SOX2, KLF4, and c-MYC. Resulting iPSC lines were rigorously characterized for pluripotency, genomic stability, and differentiation potential using alkaline phosphatase staining, SSEA-4 expression, karyotyping, teratoma formation, directed in vitro differentiation, transcriptomic analysis, and genome-wide DNA methylation profiling.
Both thymocyte and T-fib-derived iPSC lines exhibited characteristic pluripotent stem cell morphology, expressed pluripotency markers, maintained normal karyotypes, and demonstrated trilineage differentiation potential. Importantly, thymic-derived iPSCs successfully generated downstream cellular therapy candidates, including endothelial cells, cardiomyocytes, and thymic epithelial progenitors, highlighting their versatility for regenerative medicine applications. Methylation profiling via microarray revealed that early-passage thymic-iPSCs retained DNA methylation signatures reflective of their cell of origin, consistent with epigenetic memory, whereas these differences diminished with continued passaging. These findings establish discarded neonatal thymus tissue as a valuable source of patient-specific iPSCs for regenerative medicine. In the future, thymic-derived iPSCs could enable autologous cellular therapies for pediatric patients undergoing congenital heart surgery, including generation of replacement thymic tissue to restore immune function and cardiac cell therapies to repair congenital heart defects. |
| 10 | Sayandeep Saha | Matthew Brown | Hypoimmune ICAM-1 knockout human pluripotent stem cell-derived endothelial cells evade innate and adaptive immune responses under physiological conditions | Immune-mediated rejection remains a major barrier to the clinical translation of human pluripotent stem cell (PSC)-derived cellular therapies, with endothelial cells (ECs) serving as early and critical targets of host immunity in vascular grafts. Current hypoimmune strategies primarily rely on major histocompatibility complex (MHC) disruption to blunt T cell recognition but can provoke NK cell missing-self responses and are not mechanistically targeted to prevent innate immune mechanisms, particularly neutrophil-driven inflammatory injury that dominates the earliest stages of graft rejection. We recently identified intercellular adhesion molecule-1 (ICAM-1) as a promising hypoimmune target that reduces leukocyte adhesion and T cell activation in static 2D culture while preserving MHC expression and avoiding NK cell missing-self recognition. To advance this strategy toward clinical relevance, here we investigate ICAM-1 knockout (KO) PSC-derived ECs under physiologically relevant conditions that model early inflammatory events following transplantation. ICAM-1 KO PSC-ECs retained endothelial identity and function, including acetylated LDL uptake, tube formation, nitric oxide production, engraftment kinetics comparable to wild-type controls in vivo, and the ability to form perfusable 3D vascular lumens that recapitulate native vessel geometry and microenvironmental organization. Under shear flow, ICAM-1 deletion markedly reduced neutrophil adhesion to the vasculature. In complementary static and co-culture assays, loss of ICAM-1 significantly diminished neutrophil-mediated oxidative stress, consistent with impaired immune–endothelial engagement. In 2D static and 3D vascular lumen models, ICAM-1 KO endothelium profoundly suppressed neutrophil adhesion and transendothelial migration without compromising barrier integrity. Together, these findings establish ICAM-1 as a central adhesion checkpoint governing early innate immune injury. We demonstrate that ICAM-1 knockout enables the generation of structurally intact, functionally competent, and hypoimmune human vasculature under physiological conditions, offering a broadly applicable strategy to improve early graft survival in PSC-based vascular and other regenerative cell therapies. |
| 11 | Wesley Blashka | Matthew Brown | IFN-γ-Driven Endothelial Cell Activation Distinguished Allogeneic from Autologous iPSC-Modeled Rejection | Purpose. Endothelium is the first donor tissue that the recipient immune system encounters in every solid organ allograft, and its activation precedes the histologic changes on which diagnosis depends. Molecular surveillance — cell-free DNA, transcript panels, biopsy classifiers — detects rejection after damage is underway, is sensitive to sample heterogeneity, and remains agnostic to mechanism. Progress requires resolving the endothelial-immune interface itself. We asked whether co-culture of induced pluripotent stem cell-derived endothelial cells (iPSC-ECs) with allogeneic peripheral blood mononuclear cells (PBMCs) reproduces early allorejection transcription in both donor and recipient and separates from autologous interaction.
Methods. Nine single-cell RNA-sequencing libraries spanned two experiments. A single PBMC donor was co-cultured <24 hours with either autologous or HLA-mismatched iPSC-ECs, each arm with its own EC-alone control, permitting a difference-of-differences (ΔΔ) contrast that cancels cell line baseline. An independent donor pair tested replication. Because each condition is a single library, we report pseudobulk effect sizes, split-fold sign stability, and cross-pair directional concordance. Pathways were scored against MSigDB, PROGENy, and CollecTRI. Results. Allogeneic co-culture induced IFN-γ associated pathways, chemokines (CXCL9/10/11), adhesion molecules (ICAM1, VCAM1), and the upstream STAT1-IRF1 signature. Autologous co-culture induced similar changes with reduced magnitude. Of 207 genes with >2-fold all-specific induction, MHC class II separated the arms most sharply (CD74 ΔΔ +3.2, HLA-DRA ΔΔ +2.6). Every immune lineage showed matching interferon signatures. The allogeneic endothelial response replicated across donor pairs: 95% of 1690 genes agreed in direction. Conclusions. A purified iPSC-EC/PBMC platform recapitulated the interferon axis of early allorecognition with high resolution and independent replication. Because the endothelium is common to vascularized allografts, signatures defined in this system offer a mechanistic reference against which existing rejection signatures can be interpreted. With one library per condition and one autologous arm, effect size and cross-pair concordance establish the analytic baseline for the “Rejectome”. |
| 12 | Natalia Del Rio | Neonatal and Pediatric Thymic Grafts Generate Similar Human T-Cell Chimerism in Humanized Mice | Human immune system (HIS) humanized mice, especially those with human thymic tissue and hematopoietic stem/progenitor cell (HSPC) co-transplantation, provide a powerful in vivo platform to study human T-cell development, tolerance, and effector function. HIS models are key regenerative medicine tools for evaluating immunogenicity and compatibility of pluripotent stem cell-derived therapies before clinical use. The thymus is a lymphoid organ responsible for generating a diverse, self-tolerant T-cell repertoire, and its inclusion in HIS models is essential for generating major histocompatibility complex-restricted T cells. The bone marrow-liver-thymus (BLT) HIS model uses human fetal tissues of narrow gestational age (17-22 weeks). We previously developed the NeoThy™ humanized immune system mouse model, created using cord blood HSPCs and donated thymus tissue from neonatal and pediatric donors, as a non-fetal alternative to BLT. NeoThy can be used clinically to evaluate immune responses to PSC-derived therapies. While BLT uses tissue of relatively consistent gestational age, the impact of thymic donor age in NeoThy is unclear, since donors can range from a few days old to many years old. We created NeoThy cohorts using thymic tissue from donors of various ages and compared NeoThy and BLT cohorts. De novo thymopoiesis was confirmed within transplanted thymic grafts. Across independent experiments, neonatal and pediatric thymic donor tissue produced similar T-cell chimerism and function, regardless of donor age. T cells developing with a transplanted thymus showed gene expression signatures consistent with more mature responses to mRNA vaccine challenge than those observed in cord blood-only mice. These findings highlight that neonatal and pediatric thymus donor tissue generate robust human immune systems. This supports NeoThy as a clinical immunogenicity testing tool for PSC-based therapies and provides context for thymus transplantation interventions like ReThymic® and the development of future clinical PSC-derived therapies for thymus transplantation. | |
| 13 | Parnia Serjooei | In vivo engraftment dynamics of human pluripotent stem cell-derived hematopoietic stem/progenitor cells vs. primary cell controls | Hematopoietic stem and progenitor cells (HSPCs) are responsible for the lifelong production of blood and immune cells and are essential to both clinical transplantation and hematopoietic research. Primary HSPCs are typically obtained from sources such as bone marrow and umbilical cord blood, which are inherently limited by donor availability. Human pluripotent stem cell-derived HSPCs (PSC-HSPCs) offer a potentially renewable alternative with applications in regenerative medicine and humanized mouse research. However, continued characterization of PSC-HSPCs relative to primary HSPCs is necessary to assess their functionality and support their future development. In this study, primary cord blood HSPCs and immune cell populations generated in humanized mice were characterized to establish reference profiles for PSC-HSPC studies. Primary HSPC profiles were evaluated alongside immune and T-cell populations from humanized mice, including models incorporating neonatal thymus tissue to support appropriate human T-cell development and functional gene expression. These primary cell datasets provide benchmarks for evaluating PSC-HSPC differentiation and function across future studies. Establishing well-characterized reference profiles may support continued optimization of PSC-HSPCs for future clinical applications and the development of scalable humanized mouse platforms in which a single donor could ultimately provide a renewable source of cells for thousands of genetically identical, donor-specific animals. | |
| 14 | Alice Alhaj Kadour | Owen Tamplin | A novel model of diffuse midline glioma to investigate tumor initiation and identify new treatment strategies | Diffuse intrinsic pontine glioma (DIPG), now classified as H3K27M altered diffuse midline glioma (DMG), is a highly aggressive and fatal brain tumor that appears in children between 4-9 years of age. It has a median survival of 8-12 months, making it a high priority for further investigation. There are currently no models of DMG ideal for investigating early stages of tumor development. Our goal is to model the earliest stages of DMG/DIPG development and dissect the mechanisms of tumor initiation and progression. We generated a zebrafish DMG (zDMG) model by over-expressing canonical H3.1-K27M, ACVR1-mutant, and PIK3CA-mutant oncogenes in the oligodendrocyte (OL) lineage using the zebrafish myelin basic protein (mbp) gene promoter. We used mbp:Cas9 and U6-driven gRNA for CRISPR/Cas9 targeting of tp53, ptena, and ptenb tumor suppressors in the OL lineage. We observed over-proliferative mbp:GFP+ cells in the hindbrain from 7 days post fertilization. Single cell RNA-seq of zDMG cells identified an oligodendrocyte progenitor cell (OPC)-like population that was cycling and expressed early neural progenitor markers. In contrast, control mbp:GFP+ cells at this stage have differentiated and stopped dividing. Our results suggest zDMG mbp:GFP+ OPC-like cells may represent dedifferentiated OLs with plasticity conferred by mutant H3.1-K27M. Later, zDMG zebrafish exhibit visible lesions from 4 weeks post fertilization (wpf). Lesions are highly invasive and survival decreases from 10-12 wpf. Bulk RNA sequencing of zDMG lesions showed classic hallmarks of cancer with Gene Set Enrichment Analysis (GSEA) identifying hypoxia, epithelial-mesenchymal transition (EMT), and inflammatory pathways as significantly enriched in zDMG cells. We will use genetic tools, sequencing, and live imaging to understand DMG/DIPG tumor initiation and perform in vivo combinatorial drug screens to identify new candidate therapeutics. |
| 15 | Fei Sun | Ken Poss | Hb-EGF-programmed epicardium forms stromal channels that potentiate innate heart regeneration | Title: Hb-EGF-programmed epicardium forms stromal channels that potentiate innate heart regeneration Abstract: Innate heart regeneration requires expansion and invasion of cells derived from an enveloping mesothelial tissue called epicardium. Here we show that injury-induced synthesis of Heparin-derived epidermal growth factor (Hb-EGF) is essential for key epicardial cell behaviors underlying heart regeneration in zebrafish. Moreover, Hb-EGF overexpression amplifies epicardial tissue and stimulates disruptive invasion into heart muscle, sequential events that grossly enhance regeneration. Hb-EGF-activated epicardial-derived cells display merged cell states and construct muscle-wall-spanning stromal channels that promote cardiomyocyte division in multiple dimensions. Through parallel mechanisms, Hb-EGF triggers formation and expansion of ventricular wall muscle during development, both in zebrafish and in miniaturized Danionella cerebrum. Our experiments identify Hb-EGF as a required factor that programs the quiescent single-cell epicardium to expand, invade, and drive cardiomyocyte proliferation dynamics during heart morphogenesis and regeneration. |
| 16 | Hossam Ahmed | Junsu Kang | Single-Cell Dissection of Heterogeneous Cardiac Cell Responses to Interleukin-11a–Induced Regenerative Response in Zebrafish | Single-Cell Dissection of Heterogeneous Cardiac Cell Responses to Interleukin-11a–Induced Regenerative Response in Zebrafish Hossam Ahmed1, Kwangdeok Shin1, Isabella M. Silaban1, Anjelica Rodriguez-Parks1, Junsu Kang1 1Department of Cell and Regenerative Biology, School of Medicine and Public Health, Regenerative factors stimulate diverse cardiac cell types to cooperate in exquisite harmony to ensure heart regeneration. We previously identified Interleukin 11 (Il11) as a potent regenerative factor in zebrafish hearts, capable of stimulating cardiomyocyte (CM) proliferation and promoting vasculogenesis in the absence of injury. To dissect how heterogeneous cardiac cell types respond to regenerative stimuli, we performed and analyzed single cell RNA sequencing (scRNA-seq) following il11a overexpression (il11aOE). Our scRNA-seq analysis revealed a distinct subset of cardiomyocytes (CMs) that emerges upon il11aOE. This il11-responsive CM cluster is highly enriched for cell cycle-related gene expression, supporting that il11a acts as a mitogen for CMs. We are currently investigating transcription factors that mediate il11a-triggered CM proliferation. il11aOE also increases the number of ACTA2⁺ primordial CMs by approximately two-fold. Our scRNA-seq analysis further showed that crb2a is highly enriched in ACTA2+ primordial CMs. Notably, Crb2 polarity in these primordial CMs is significantly shifted from apical to junctional localization upon il11a induction, suggesting CM polarity is remodeled in response to il11a. In addition to CMs, il11aOE markedly expands epicardial (Epi) and epicardial-derived cells (EPDCs), giving rise to 6 distinct sub-clusters. These heterogeneous populations include Periostin⁺ (Postn) fibroblasts and ptx3a⁺ Epi/EPDC subsets. The ptx3a+ Epi/EPDC exhibits high expression of angiogenic factors, suggesting a role in activating coronary vessels and promoting vasculogenesis. Overall, these results provide molecular insight into how regenerative cytokine signaling reshapes the transcriptional states and cellular composition of the heart, revealing coordinated cell-type–specific programs that enable cardiac tissues to mount a regenerative response. |
| 17 | Megan Guyer | Junsu Kang | Decoding regulatory logic underlying cardiac regeneration enhancers in zebrafish. | Zebrafish have remarkable regenerative potential in the heart, which relies on the activation of gene regulatory networks in response to cardiac injury. This activation is orchestrated by diverse classes of tissue regeneration enhancer elements (TREEs), and understanding how these TREEs are precisely regulated during regeneration will elucidate the regulatory logic controlling heart regeneration. To address this, we focused on two distinct regeneration-specific cardiac TREEs that drive injury-inducible expression but remain inactive during development. The first TREE is the cardiac leptin b regeneration enhancer (cLEN), whose activity is tightly regulated by maturation-associated repression and injury-induced activation. To identify a broader set of cLEN-like cardiac TREEs, we performed a genome-wide survey for the cLEN enhancer code in zebrafish and filtered for candidate enhancers with epigenomic and transcriptomic profiles. Through this computational analysis, we identified 48 regeneration-responsive enhancer candidates. Mosaic transgenic assays further validated several injury-responsive, heart-specific enhancers containing cLEN-like features, including enhancers associated with tnfaip6, pcgf5b, and wnt2bb. The second TREE is linked with il11a, a regenerative factor capable of triggering the cardiac regeneration program in the absence of injury. Our studies identified two il11a regeneration enhancers (il11aEN1 and il11aEN2) in zebrafish that are active upon heart and fin injury. Enhancer bashing assays revealed separable fin and heart modules within il11aEN1. Notably, il11aEN1-fin, but not il11aEN1-heart, exhibits greater sequence conservation with an analogous il11a enhancer sequence in medaka. Collectively, these studies will begin to decode the regulatory logic governing cardiac regeneration enhancers in zebrafish. |
| 18 | Sophie Karp | Investigated the effects of Hypoxia and NOTCH3 on Human IPSC-Derived Epicardial Cells | BACKGROUND: Poor cardiac recovery after myocardial infarction (MI) leads to significant morbidity and mortality. To reduce this burden, we propose tapping into the heart’s innate regenerative system via the epicardium. The epicardium is the innermost layer of the pericardium, plays a large role in cardiac organogenesis, and aids in regeneration post-infarction. After a heart attack, cells in the epicardium migrate to the site of infarct and differentiate into mesenchymal cells that support new cardiac tissue and vasculature. This differentiation is called the epicardial to mesenchymal cell transition (EMT).
AIM: We investigate iPSC-derived epicardial cells in hypoxic conditions to mimic MI. We aim to identify a therapeutic target which could aid EMT peri-infarct. One of our top candidates is NOTCH3, which plays an important role in cardiac development. METHODOLOGY: We mimic hypoxia to model MI in vitro via 1. Culturing cells in a hypoxia chamber and 2. With cobalt chloride, a common hypoxia inducing agent. We then compare expression of EMT markers, hypoxia induction pathway markers, and epicardial maintenance identity markers via ICC and flow cytometry. We look at both changes after hypoxia culture and after simulated reperfusion injury by re-exposing cells to ambient oxygen conditions. We then investigate changes in these markers in the presence of NOTCH3. RESULTS: We found differences in EMT expression in the presence of NOTCH3 and hypoxia, including decreased epicardial marker expression. We also found differences in hypoxia marker expression. CONCLUSION/DISCUSSION: Our results demonstrate a potential for the NOTCH3 pathway to be targeted peri-infarct as a means of promoting cardiac regeneration. Furthermore, as there is no published literature investigating the effects of hypoxia in human epicardial/ epicardial-like cells in vitro, we have also established a new platform for studying EMT. |
|
| 19 | Bayley Waters | Valentina Lo Sardo | Generating novel isogenic iPSC lines to assess the role of the VAMP risk locus in coronary artery disease risk | Background: Coronary artery disease (CAD) is a leading cause of death in the United States and worldwide. Genome-wide association studies (GWAS) have shown a relationship between thousands of common genetic variants (SNPs) and risk of developing CAD. Many SNPs associated with CAD risk are in high linkage disequilibrium (LD), meaning that SNPs within the same region are inherited together, obfuscating the role of individual SNPs on CAD risk. LD varies across human populations, with some populations exhibiting lower LD among SNPs at several genomic regions and a concurrent lack of associated risk for CAD, suggesting that LD among multiple SNPs may play a direct role in CAD risk disposition. One such newly identified risk locus includes a region containing the genes VAMP5 and VAMP8, which contain SNPs in high LD and associated with CAD risk in individuals of European genetic ancestry. However, lack of LD in this region in individuals of African descent poorly correlates with risk of CAD. The function of single variants and genes in this locus has not been defined in vascular smooth muscle cells (VSMCs) and endothelial cells (ECs), which form the arterial wall and undergo extensive phenotypic alterations during CAD. Methods: To create a relevant, human genetics-based model to study the VAMP risk locus in blood vessel cells, we applied CRISPR-based gene editing in human induced pluripotent stem cells (iPSCs) to generate isogenic iPSC lines with deletions within the VAMP locus. We designed guides to target different-sized regions within the VAMP locus, encompassing sets of SNPs in high LD as well as genes within this locus. These cell lines are then differentiated into VSMCs and ECs to assess the impact of VAMP locus removal on vessel cell type differentiation and identity. Results: Here, we demonstrate that high LD portions of the VAMP5-8 risk region can be deleted in iPSCs while maintaining cell viability and pluripotency. Cell lines with targeted deletion of the high-LD region containing the genes VAMP5 and VAMP8 can be differentiated into VSMCs which express identity markers aSMA, CNN1, and TAGLN, indicating that the region containing VAMP5 and VAMP8 is not essential for VSMC differentiation or identity. Discussion: These cell lines provide a novel model to study the VAMP5-8 risk haplotype in vascular smooth muscle and endothelial cell types, and to assess phenotypic and functional consequence of VAMP5-8 risk region modulation. Further application of this modeling system in iPSCs from heterogeneous genetic backgrounds will provide insights into the role of the VAMP5-8 locus in variable CAD risk across human populations. |
| 20 | Elsa Salido | Valentina Lo Sardo | Genetic Variation at 9p21.3 Promotes Atherosclerotic Reprogramming of Vascular Smooth Muscle Cells | Introduction. GWAS studies have identified approximately 300 genomic loci linked to increased coronary artery disease (CAD) risk, of which the most impactful is the 9p21.3 locus. This ~60 kb region is a gene desert containing ~80 SNPs in high linkage disequilibrium, defining two possible alleles: the risk allele, increasing risk of CAD by up to 60%, or non-risk, with no significant impact on CAD risk. Despite its strong impact and the fact that it was identification nearly 20 years ago, the function of the 9p21.3 risk locus remains incompletely understood. We hypothesize that the 9p21.3 region contributes to CAD risk by mediating aberrant phenotypic modulation in vascular smooth muscle cells (VSMC).
Method. We used induced pluripotent stem cells (iPSCs) from 9p21.3 risk and non-risk donors to create isogenic lines with a full haplotype deletion, generating four genotypes: risk WT, risk KO, non-risk WT, and non-risk KO. Using two independent iPSC lines per genotype (8 lines total), we conducted a differentiation to VSMC and employed single-cell transcriptomic profiling. We then performed co-embedding and comparison with publicly available human coronary artery scRNAseq datasets, validated the hits from our analysis by immunocytochemistry, and performed functional assays to test the impact of the transcriptional changes. Finally, we used knockdown and overexpression experiments to further examine the impact of key genes identified in our analysis. Results. Our study shows that iPSC-VSMCs carrying the 9p21.3 risk haplotype adopt an osteochondrogenic state. The altered transcriptional profile is characterized by decreased migration capacity and increased calcification, revealing a phenotype closely resembling fibrochondrocytes, which are an osteochondrogenic state known to contribute to CAD pathogenesis. Additionally, we observe a strong transcriptional overlap between iPSC-VSMCs and native human VSMCs from heart arteries, validating the utility of our model to study human disease. Finally, we identify two novel 9p21.3 risk-biased signature genes, LIMCH1 and CRABP1, which appear to be critical in defining the risk state. Conclusions. Our study demonstrates that 9p21.3 drives disease-relevant phenotypic modulation in VSMCs consistent with an osteochondrogenic-like state called fibrochondrocytes. We observe that the 9p21.3 risk region exerts its influence in a cell type-specific and cell-autonomous manner, promoting CAD-relevant phenotypes like arterial stiffening and calcification. This work contributes to our knowledge of how 9p21.3 can increase risk of CAD, thus aiding efforts to mitigate genetic risk for the disease. |
| 21 | Shraddha Suryavanshi | Valentina Lo Sardo | Long-Read Transcriptomics Identifies 9p21.3–dependent Splicing Reprogramming in Smooth Muscle Cells | Genetic susceptibility to coronary artery disease (CAD) is associated with variants at more than 300 genomic loci, among which the 9p21.3 locus shows the strongest and most consistent association. Despite its prominence, the mechanisms by which this locus influences vascular cell behavior remain poorly understood. This ~60 kb gene desert contains ~80 single-nucleotide polymorphisms (SNPs) in high linkage disequilibrium, defining two major haplotypes: risk and non-risk. We previously demonstrated that the 9p21.3 CAD risk haplotype promotes an osteochondrogenic phenotype in vascular smooth muscle cells (VSMCs). Notably, many genes dysregulated in risk VSMCs are involved in mRNA splicing. We used iPSCs heterozygous at the 9p21.3 locus were genome edited to generate haplotype-biased hemizygous lines. iPSCs were differentiated into VSMCs and analyzed using long-read RNA sequencing to quantify transcript expression, isoform usage, and splicing patterns. CRISPR interference (CRISPRi) was used to functionally validate candidate splicing regulators in mature VSMCs. The 9p21.3 risk allele altered the expression of more than 800 transcripts, including genes critical for vascular homeostasis, remodeling, and CAD pathogenesis. Long-read RNA sequencing revealed distinct transcriptional programs driven by the two haplotypes. The risk haplotype drives extensive genome-wide reprogramming of mRNA splicing resulting in disrupted transcript isoform expression and usage, frequently independent of total gene expression changes, promoting aberrant VSMC phenotypic modulation. Among the affected genes, we prioritized and validated the RNA helicase DDX5 as a downstream effector of the 9p21.3 locus. The 9p21.3 CAD risk haplotype exerts a previously unrecognized role in regulating genome-wide RNA splicing in VSMCs, affecting both gene expression and alternative isoform usage of multiple CAD-related genes. This study provides the first comprehensive isoform-level comparison of the two major 9p21.3 haplotypes and identifies allele-specific transcriptional programs that reshape VSMC splicing landscapes and phenotypic plasticity. |
| 22 | Hannah Szmurlo | J. Carter Ralphe | Quantifying the S-glutathionylation of cardiac myosin binding protein-C in mouse hearts & hiPSC-cardiomyocytes | Hypertrophic Cardiomyopathy (HCM) is a genetic cardiovascular disease characterized by thickening of the heart and impaired cardiac function. Mutations within gene encoding cardiac myosin binding protein-C (cMyBP-C), MYBPC3, are a leading cause of HCM. cMyBP-C is a regulatory protein in the sarcomere that controls the rate of cross-bridge cycling, modulating cardiac contraction and relaxation. cMyBP-C function is affected by post-translational modifications (PTM), like S-glutathionylation. S-glutathionylation is a reversible PTM that is increased during oxidative stress, when the ratio of reduced glutathione (GSH) to oxidized glutathione (GSSG) is reduced. We aimed to better understand the role of cMyBP-C S-glutathionylation on cardiac function by treating human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) and mouse hearts with compounds that alter S-glutathionylation levels. Ventricles dissected from wild-type and cMyBP-C knockout mice were treated with GSSG to determine total cMyBP-C S-glutathionylation relative to the total amount of cMyBP-C present when mimicking oxidizing conditions. HCM mutant and control hiPSC-CMs were treated with either et-GSH or a vehicle control of DPBS in standard media to determine if GSH treatment can reverse S-glutathionylation in HCM. The level of S-glutathionylation was measured using western blotting. GSSG treatment (5mM and 10mM) greatly increased the S-glutathionylation of cMyBP-C in wild-type mouse hearts. We did not detect cMyBP-C S-glutathionylation in hiPSC-CMs; likely due to the low concentration of solubilized cMyBP-C. Future directions include using mass spectrometry to increase the sensitivity of capturing a S-glutathionylation signal and increasing hiPSC-CM seeding density to increase the concentration of cMyBP-C in protein lysate. |
| 23 | Leah Nelson | J Carter Ralphe | Heart-Forming Organoid Characterization | Congenital abnormalities arising during organogenesis are a leading cause of infant mortality, morbidity, and long-term complications in children. In 2021 there were 7.2 million cases of congenital birth defects and 0.53 million associated deaths globally. Despite the clinical significance, the earliest stages of human organogenesis remain poorly understood due to ethical limitations on human embryo research and the lack of in vitro models that accurately recapitulate early developmental processes. Directed differentiation of human pluripotent stem cells (hPSCs) provides a powerful platform for modeling human embryonic development. Recently, heart-forming organoids (HFOs) were developed to reproduce the earliest stages of heart and foregut co-development, closely mimicking embryonic heart anlagen and foregut endoderm. This model captures developmental processes that are absent from conventional cardiac differentiation systems. In this study, HFOs were generated using the established differentiation protocol developed by Drakhlis et al. and characterized through whole-mount immunofluorescence staining and confocal microscopy. The objective was to further evaluate whether HFOs recapitulate the structural organization and lineage specification characteristic of early human cardiogenesis. |
| 24 | Jeanne Hsieh | Tim Kamp | Cardiomyocyte-Fibroblast Interactions Drive Electrical Dysfunction in a Patient-Derived Model of Concealed-Phase Arrhythmogenic Cardiomyopathy | Cardiomyocyte-Fibroblast Interactions Drive Electrical Dysfunction in a Patient-Derived Model of Concealed-Phase Arrhythmogenic Cardiomyopathy
Background: Arrhythmogenic cardiomyopathy (ACM) is characterized by ventricular arrhythmias that can precede detectable structural remodeling, yet mechanisms underlying this concealed electrical phase remain poorly understood. Most human induced pluripotent stem cell (hiPSC) models focus on cardiomyocyte (CM)-intrinsic defects, leaving the contribution of cardiac fibroblasts (CFs) unresolved. We studied a patient carrying PKP2 p.L709F who presented with exercise-associated sustained ventricular tachycardia despite normal cardiac MRI and later developed right ventricular remodeling. Hypothesis: PKP2 p.L709F produces a CM-intrinsic conduction defect that is further modulated by pathogenic interactions with second heart field-derived cardiac fibroblasts (SHF-CFs). Methods: Patient-derived PKP2 p.L709F hiPSCs and a CRISPR/Cas9-corrected isogenic control were differentiated into hiPSC-CMs and SHF-CFs. CMs were studied in monoculture and in micropatterned co-cultures containing mutant or gene-corrected SHF-CFs. An independent control hiPSC-CM line was also co-cultured with mutant or corrected SHF-CFs. Electrical propagation was quantified by FluoVolt optical mapping, and junctional connexin-43 (Cx43) organization was assessed by immunocytochemistry. Results: Mutant hiPSC-CMs exhibited slower conduction than gene-corrected hiPSC-CMs in monoculture, demonstrating a CM-intrinsic phenotype. This defect was further exacerbated in line-matched mutant co-cultures. Genotype-mismatched experiments revealed an independent fibroblast contribution: mutant SHF-CFs impaired electrical propagation, whereas gene-corrected SHF-CFs partially rescued conduction in mutant hiPSC-CMs. Mutant SHF-CFs also reduced conduction in an independent control hiPSC-CM line. Mutant line-matched co-cultures exhibited reduced junctional Cx43 organization compared with corrected controls. Mutant SHF-CFs were also associated with reduced upstroke velocity, consistent with impaired intercellular coupling and/or CM excitability. Conclusions: These findings identify both CM-intrinsic and fibroblast-dependent mechanisms of electrical dysfunction in PKP2-associated ACM and reveal a prominent contribution of SHF-CF genotype to conduction. This human multicellular model enables mechanistic investigation of concealed-phase arrhythmogenesis and provides a platform for identifying early therapeutic targets before overt structural remodeling. |
| 25 | Jamie Hernandez | Amish Raval | Differentiation of Swine iPSCs into Cardiomyocytes | Human induced pluripotent stem cell derived cardiomyocytes (iPSC-CM), a new therapeutic approach to treat heart failure (HF), were recently approved in Japan despite limited mechanistic data. Efforts to investigate host-graft interactions, engraftment durability and functional recovery in preclinical HF model have been constrained by xenogeneic immune barriers. These mismatches require immunosuppression, introducing toxicities, and obscuring interpretation of graft biology, dosing, myocardial targeting, and potential off target effects. A robust, large-animal preclinical model that removes xenotransplant complications is essential. Swine, with cardiac anatomy and physiology similar to humans, offer an ideal system, but this requires the ability to generate porcine iPSC derived cardiomyocytes. Establishing porcine iPSC CMs is thus a critical first step, enabling syngeneic or allogeneic transplantation with minimal immunosuppression and providing immunologically compatible model to elucidate mechanisms underlying iPSC CM therapy. Swine iPSC from Wisconsin Miniature Swine (WMS) were differentiated into cardiomyocytes using a protocol sequentially directing cells through key developmental stages: primitive streak (day 0), lateral mesoderm (day 1), cardiac mesoderm (days 2-4), and cardiomyocytes (day 4+). Cell phenotype was assessed via imaging and quantitative polymerase chain reaction (qPCR) to identify markers that establish pluripotency, germ layer, and mesoderm sub-lineages (NKX2.5-cardiac mesoderm, and cardiac troponin/TNNT2-cardiomyocytes). We observed that initial cell seeding on feeder-free culture substrates had a critical impact on swine iPSC-CM generation. Establishing a confluent monolayer of iPSCs prior to treatment with differentiation medium proved necessary to create functional, beating cardiomyocytes. Swine iPSC-CMs, adapted to feeder-free conditions, exhibited increased expression of cardiac genes (TNNT2 and NKX2.5) and an elongated morphology indicative of greater cell maturity visualized by cardiac troponin staining. In summary, we report the first successful differentiation of iPSC-CM from WMS. Future efforts will compare human/porcine iPSC-CM characteristics, evaluate cell interactions, engraftment, and functional responses in syngeneic and allogeneic swine HF models using no or minimal immunosuppression. |
| 26 | Chanhyung Park | Sean Palecek | Single-Cell Transcriptomics Maps Lineage Divergence and Candidate Regulators across hPSC-Cardiomyocyte Differentiations of Varying Purity | Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) provide a renewable source of human cardiac cells for disease modeling, drug testing, and regenerative medicine. However, their production remains difficult to control, and nominally similar differentiations can yield markedly different cardiomyocyte purities. Because quality is often assessed only at the endpoint, the cellular and regulatory changes that precede successful or inefficient differentiation remain incompletely understood. We are developing a time-resolved single-cell framework to determine when differentiation outcomes separate, which cellular programs underlie those differences, and when intervention may be most effective. To connect evolving cell states with final product quality, we profiled the H9 human embryonic stem cell line by single-cell RNA sequencing at ten time points spanning days 0–7, 10, and 15. The three differentiation outcomes yielded 94.0%, 82.8%, and 26.6% day-15 cTnT+ purity, quantified by immunocytochemistry and flow cytometry. Preliminary analysis identified pluripotent, mesodermal, cardiac, endothelial, and endodermal populations. Outcome-associated differences were apparent around day 4, one day after Wnt inhibition. The low-purity outcome retained substantial endodermal representation, whereas the two higher-purity outcomes, despite differing by 11.2 percentage points, showed distinct temporal distributions of cardiac transitional states. These findings suggest that suboptimal differentiation may arise through multiple cellular routes rather than a single failure mechanism. To move from description toward testable mechanism, we inferred cell-state-specific gene-regulatory networks and used betweenness centrality as a network-level strategy to prioritize potentially influential transcription factors. Established cardiac regulators ranked highly, and simulated TBX5 overexpression predicted state-dependent shifts toward cardiomyocyte-associated states, nominating candidate intervention windows. Ongoing integration of 19-9-11 and IMR90-4 differentiation series will test which patterns are conserved across embryonic and induced pluripotent stem cell backgrounds and donor sex. This framework aims to identify generalizable failure-associated programs and enable more predictable, mechanism-informed hPSC-CM manufacturing. The main improvement is that the abstract now frames your current results as the first application of a broader comparative framework, rather than as the completed endpoint of the project. |
| 27 | Janay Walters | Lee Eckhardt | LMNA Mutation Drives Electromechanical Remodeling and Arrhythmogenicity in Human iPSC-Derived Cardiac Microtissues | LMNA mutations cause a heterogeneous spectrum of disorders, including lipodystrophy, progeria, skeletal and cardiomyopathies. Cardiac laminopathies frequently present with arrhythmia as the initial manifestation and are classified as arrhythmogenic cardiomyopathy (ACM). Although Lamin A/C is integral to nuclear envelope integrity, how pathogenic LMNA variants disrupt Lamin A/C structure in cardiomyocytes (CMs) and cardiac fibroblasts (CFs) to produce a distinct electrophysiologic phenotype remains unclear. Notably, ACM-associated LMNA+/E203K has not been physiologically characterized in vitro. We generated LMNA+/E203K heterozygous DT19-9-11T iPSCs by CRISPR/Cas9 genome editing. iPSC-derived CMs and CFs were differentiated and co-cultured to form cardiac microtissues on PDMS substrates with stiffnesses representative of healthy (10 kPa) and diseased (50 kPa) myocardium to introduce changes in the mechanical environment. Optical voltage and calcium mapping revealed a striking arrhythmogenic phenotype in LMNA+/E203K microtissues characterized by spatially unstable spontaneous activation sites and post-pacing rate acceleration that was enhanced on 50 kPa substrates, consistent with abnormal automaticity and impaired rate adaptation. Compared with controls, LMNA+/E203K tissues exhibited prolonged action potential duration during 1.5 Hz pacing at 10 kPa stiffness, with no differences at 50 kPa and displayed increased Ca2+ transient duration only on 50 kPa substrates. Confocal imaging of LMNA+/E203K iPSC-CMs and CFs showed decreased nuclear circularity and cytoskeletal disorganization on 10 kPa substrates, which was further exacerbated on the 50 kPa compared to control. Collectively, these findings demonstrate that ACM-associated LMNA+/E203K mutation produces a highly arrhythmogenic cardiac microtissue phenotype characterized by abnormal automaticity and prolonged refractoriness. These electrophysiologic defects are accompanied by impaired nuclear mechanoadaptation in both CMs and CFs with stiffness-dependent cytoskeletal disorganization, indicating disrupted nuclear-cytoskeletal integration. Together, these results identify defective electromechanical coupling as a key mechanism in LMNA-associated ACM and establish a translational platform to study how nuclear lamina alterations in CMs and CFs drive electrophysiologic dysfunction. |
| 28 | Jodi Lawson | Lee Eckhardt | Functional Analysis of hiPSC-derived CM and CF Crosstalk in LMNA Cardiomyopathic Mutation | “Functional Analysis of hiPSC-derived CM and CF Crosstalk in LMNA Cardiomyopathic Mutation”
The LMNA gene encodes nuclear lamins A and C, intermediate filaments with roles in gene regulation, chromatin organization, and nuclear stability. LMNA mutations lead to a broad set of inherited diseases called laminopathies. Among these, cardiac laminopathies present early with conduction defects and arrhythmias, and progressive cardiomyopathy. The major cellular phenotype has focused on characterization of cardiomyocytes, yet cardiac fibroblasts may also contribute to disease progression. The specific role of cellular crosstalk between cardiac fibroblasts and cardiomyocytes remains unclear. We hypothesize that the arrhythmic phenotype observed in LMNA mutations is dependent on cellular crosstalk between hiPSC-cardiomyocytes (CMs) and hiPSC-cardiac fibroblasts (CFs) and that co-culture groups will exhibit differentially expressed intercellular signaling mediators that correlate with electrophysiologic and mechanical dysfunction. To test this hypothesis, we introduced heterozygous LMNA+/E203K mutation, a LMNA mutation associated with cardiac laminopathy, using CRISPR-gene editing into a non-diseased control iPSC line (19-9-11 iPSC). We then designed four experimental groups of co-cultured iPSC-CMs and iPSC-CFs: non-diseased control co-culture, LMNA+/E203K co-culture, non-diseased control CM/ LMNA+/E203K CF, and LMNA+/E203K CM/healthy CF. Mechanical function was quantified with digital image correlation (DIC) to extract contractile kinetics while electrophysiology was assessed using optical mapping (OM). Culturing mutant fibroblasts with healthy myocytes accelerated the spontaneous beating rate, shortened time to peak contraction, increased calcium transient amplitude, and accelerated calcium handling dynamics. Pairing mutant myocytes with healthy fibroblasts mitigated the slow contractile kinetics and spontaneous beating rates observed in full-mutant co-cultures, while partially recovering calcium rise and decay times. These results demonstrate that iPSC- CM and CF crosstalk modulates the functional phenotype of LMNA+/E203K mutations. Future transcriptomic analysis will provide insights to driving mechanisms behind calcium handling and contractile behavior. |
| 29 | Lauren Anderson | Melissa Skala | Label-free Metabolic Imaging of Stimulated Cardiac Fibroblast Subtypes | Label-free Metabolic Imaging of Stimulated Cardiac Fibroblast Subtypes Lauren Anderson (1), Harmehak Kaur (1,2), Hannah Chen (3), Melissa Skala (1,2) (1) Department of Biomedical Engineering, University of Wisconsin, Madison (2) Morgidge Institute for Research, Madison, WI (3) Department of Biomedical Engineering, Texas A&M University, College Station, TX Cardiovascular disease is the global leading cause of death and highlights the need for improved human relevant in vitro systems. Human pluripotent stem cells (hPSCs) provide a human relevant platform to study cardiac development and disease. Cardiac fibroblasts are crucial for heart tissue repair through generating extracellular matrix (ECM) proteins. Prior research demonstrates that human cardiac fibroblast subtypes (primary and hSPC) have functional differences, and disease models can be improved by understanding these differences. Cardiac fibroblasts are activated by chemical triggers such as TGF-β to repair tissue damage; however, overactivation can lead to fibrosis, which impairs cardiac function. The activation pathway upregulates glycolysis, causing distinct metabolic changes. These metabolic differences can be characterized through two-photon fluorescence lifetime imaging microscopy (FLIM) of NAD(P)H and FAD, key metabolic coenzymes. Only the reduced NAD(P)H and oxidized FAD are autofluorescent and exhibit different fluorescence lifetimes based on protein binding state. FLIM was used to capture metabolic differences between ventricular, atrial, and hPSC cardiac fibroblasts. To further understand metabolic differences between subtypes, fibrotic markers were used to identify activation during stimulation. Fibroblasts were stimulated with TGF-β and treated with the TGF-β receptor inhibitor SB-431542 to suppress the activation pathway. Epifluorescence microscopy with immunofluorescent antibody staining captured changes in 𝛼SMA expression, which indicates activated fibroblasts. The results showed atrial and ventricular fibroblasts had comparable metabolic states with similar NAD(P)H mean lifetimes. HPSC-derived cardiac fibroblasts had a higher NAD(P)H mean lifetime than primary fibroblasts, suggesting a lower glycolytic baseline. Following stimulation, the 𝛼SMA expression trend varied between cardiac subtypes. For the SB inhibitor + TGF-β condition, 𝛼SMA expression increased in the hPSC subtype compared to atrial and ventricular, indicating different functionality. |
| 30 | Amy Kraak | Monica Yun Liu | BAL-Derived Airway Organoids Reveal Epithelial Changes Associated with Acute Lung Transplant Rejection | BAL-Derived Airway Organoids Reveal Epithelial Changes Associated with Acute Lung Transplant Rejection
INTRODUCTION: Acute cellular rejection (ACR) is a common complication after lung transplantation that results in immune-mediated injury to the lung allograft and worsens patient outcomes. We sought to identify mechanisms of epithelial injury downstream of immune activation that may inform future therapeutic strategies. Focusing on the airway epithelium as an epicenter of injury in rejection, we generated airway organoids from the bronchoalveolar lavage (BAL) fluid of patients with and without ACR. METHODS: BAL was collected from 5 lung transplant patients with biopsy-proven ACR and 3 patients without rejection. Using established methods, we generated airway organoids and expanded them for 2-5 passages. BAL-derived organoids were analyzed by scRNA-seq using standard Seurat packages. Differentially expressed genes were validated using RT-qPCR in an independent cohort of 8 organoid samples (5 ACR, 3 control). RESULTS: Airway organoids derived from BAL samples contained four major epithelial populations: basal, cycling basal, suprabasal, and secretory cells. Comparative single-cell transcriptomic analysis demonstrated broad upregulation of inflammatory pathways and downregulation of homeostatic epithelial processes in organoids from patients with ACR. Genes shared across two or more epithelial clusters were prioritized for validation. RT-qPCR confirmed upregulation of genes involved in immunoregulatory signaling (HLA-DRB1, MUC1, ARTN), epithelial repair (KRT5, KRT8, POU6F2), and fibrosis (MUC4, NETO1). DISCUSSION: Our results share similarities to recent transcriptomics from patient samples with various forms of rejection, indicating that our organoids can accurately reflect disease phenotypes. Future studies include further pathway investigation using our airway organoid models to identify potential therapeutic targets. |
| 31 | Shreyas Raini | Monica Yun Liu | Organoids are increasingly used as versatile, patient-derived models for studying progenitor cell behavior, development, and disease. However, as organoid experiments expand across larger numbers of samples, passages, and time points, image quantification can become a major bottleneck. Manual counting and size measurement are time-intensive, limit throughput, and can introduce variability between analyses.
To address this limitation, we developed an automated image-analysis pipeline using custom-trained Cellpose-SAM models to detect, count, and measure lung organoids. Cellpose-SAM is a generalist algorithm commonly used for segmenting, or identifying boundaries between, cells. However, the default model was unable to segment organoids accurately. Because organoid morphology changes across passages, we trained two separate models. The early-passage model was optimized for images containing small developing structures, where distinguishing newly formed organoids from individual cells and cellular debris is challenging. A second, more generalized later-passage model was trained to identify well-established organoids of varying sizes. Following segmentation, individual organoids are automatically counted and measured. These outputs allow assessment of organoid growth across passages and experimental conditions. We have applied the models to patient-derived lung organoid cultures to study acute cellular rejection (ACR) after lung transplantation. Quantifying both OFE and organoid size measurements allows us to capture complementary aspects of epithelial progenitor behavior, and may provide a more detailed picture of the epithelial injury and repair response associated with ACR. By reducing the image-analysis bottleneck, automated quantification of organoids will facilitate higher-throughput comparisons across patients, passages, and time points. |
|
| 32 | Sophie Petta | Monica Yun Liu | Donor-Recipient Origin of BAL-Derived Organoids and Immune Cells From Lung Transplant Patients | Introduction: Rejection is the leading cause of death after lung transplantation, but its underlying mechanisms are poorly understood. We developed a novel method to model rejection by generating alveolar and airway organoids from lung transplant recipients’ bronchoalveolar lavage (BAL) fluid. Since BAL is taken from the donor’s lung in the recipient’s body, an important question is whether the organoids contain cells from the donor or recipient. We hypothesized the organoids will contain predominantly donor-derived cells while the BAL immune cells will contain predominantly recipient-derived cells.
Methods: We expanded the organoids to passage 2, enzymatically digested the organoids to a single cell suspension, and performed short tandem repeat (STR) analysis. STR identifies the number of repeated sequences at loci across the genome, revealing an individual’s unique genetic signature. By comparing the organoids’ STR profile to a control containing only recipient-derived cells, we quantified the relative contributions of recipient- and donor-derived cells. We also performed STR analysis on BAL fluid, which predominantly contains immune rather than epithelial cells. Results: We analyzed 7 lines of alveolar organoids and found that they were donor-derived. We analyzed 12 lines of airway organoids and found that some samples were donor-derived, some recipient-derived, and some a mixture. We also analyzed 9 lines of BAL immune cells which contained predominantly recipient-derived cells. Discussion: Our results supported the hypothesis that the epithelial organoids taken from inside the transplanted lung contain mostly donor-derived cells while the BAL immune cells contain mostly recipient-derived cells. However, there was patient-to-patient variation. Thus, we can obtain epithelial and immune cells from two individuals from a single transplant BAL sample. Future work will include developing a method to isolate and culture pure populations of donor and recipient cells, followed by establishing a system to co-culture epithelial and immune cells to model lung transplant rejection. |
| 33 | Anik Biswas | Deneen Wellik | Loss of Hox5 function impairs alveolar fibroblast differentiation and results in the attenuation of pulmonary fibrosis | The Hox paralogous group 5 (HoxPG5) genes—Hoxa5, Hoxb5, and Hoxc5—are essential for vertebrate body patterning and play critical, redundant roles in lung development. While HoxPG5 expression is highest during the first two postnatal weeks, correlating with alveologenesis, it persists into adulthood, specifically within the lung fibroblasts. Using a Tbx4-driven conditional mutant line to knock out Hoxa5 within a Hox5bbcc null background, we demonstrated that Hoxa5 expression is significantly enhanced in actively fibrotic regions of the mouse IPF model. This correlates with higher HOXA5 expression in fibrotic regions of human lung tissue compared with less fibrotic regions, supporting the relevance of these studies to human health and disease. In adult Hox5 conditional loss-of-function mice, fibrotic injury is strongly attenuated in response to bleomycin treatment compared to controls. Bleomycin-treated mutant lungs initially respond to injury similarly to controls, with strong epithelial CCL2 expression and extensive macrophage infiltration. However, Hox5 mutant lung alveolar fibroblasts do not transition to SAA3-expressing inflammatory fibroblasts, and only a few Cthrc1-expressing fibrotic fibroblasts are observed, supporting a key role for Hox5 genes in fibroblast differentiation in response to lung injury. Intriguingly, our preliminary data show that p21-expressing stress-activated fibroblasts are increased in Hox5 mutant lungs, supporting redirection of fibroblast state transitions. |
| 34 | Carmella Whittaker | Randolph Ashton | Scalable, AI-based Quantitative Analysis of Immunostained Single-Rosette Neural Organoids | Scalable, AI-based Quantitative Analysis of Immunostained Single-Rosette Neural Organoids
Carmella Whittaker, Tatum Hedrick, Frank Seipel, Randolph S. Ashton Segmenting and quantifying microscopy images of immunostained 3D tissues often requires protracted manual labor that is prone to quantitative inconsistency and biases. With AI-based segmentation models such as Cellpose-SAM, 3D image segmentation and quantification can be scaled while maintaining analytical consistency. This poster describes progress toward developing an algorithm that manages image processing, Cellpose-SAM segmentation, and quantification of nuclear and cytoplasmic cells features in immunostained human pluripotent stem cell (hPSC)-derived neural organoids. Validation of nuclear and cytoplasm stain masking models, integration with high-throughput computing clusters, and development of algorithmic spatial analysis will facilitate neural organoid research by making quantitative cytoarchitectural analysis more scalable, precise, and reproducible. Carmella Whittaker acknowledges the support of NIH/NIGMS 5R01GM154933, “Guided Intracellular Delivery using Precise Area Introduction and Transfection (PAINT)”, and NSF Engineering Research Center for Cell Manufacturing Technologies (CMaT) #1648035 in producing the data analyzed on this poster. |
| 35 | Luis Fonseca | Randolph Ashton | Evaluating Antisense Oligonucleotide Therapeutics for Neurodevelopmental Disorders | Gene regulation is essential for human biological function, and errors in protein or RNA production can lead to severe disorders that are often unable to be targeted by traditional small-molecule therapeutics. Antisense oligonucleotides (ASOs) are single-stranded synthetic nucleotide sequences designed to bind to specific RNA strands, offering targeted RNA modulation through degradation, competitive inhibition, or splicing alteration without permanently altering the genome. Evaluating ASO candidates requires aligning disorder mechanisms, target transcript boundaries, and strategic chemical modifications to optimize binding affinity, target specificity, and resistance to enzymatic degradation.
To bridge the gap between computational candidate design and scalable experimental validation, we established an integrated ASO development pipeline paired with the RosetteArray™ platform designed by the Ashton Lab. The RosetteArray™ utilizes human pluripotent stem cell (hPSC)-derived neural rosettes in up to a 96-well format, effectively modeling early central nervous system development to enable reproducible, high-throughput phenotypic screening of neurodevelopmental disorders (NDDs). By combining sequence-level optimization with human-relevant neural tissue models, this framework rapidly prioritizes high-potential ASO designs prior to downstream testing. As proof of concept, the foundational workflow established by this pipeline has been leveraged to evaluate splice-switching ASO candidates targeting monogenic NDDs, restoring functional cellular phenotypes in neural organoid systems as seen with Timothy Syndrome type 1. Future work will deploy the RosetteArray™ platform to run automated, high-throughput screens, validate ASO efficacy across diverse NDD targets, and continuously refine the therapeutic design workflow. |
| 36 | Tatum Hedrick | Randolph Ashton | Optimization of Transient Transcriptomic Modulation within an Arrayed Neural Organoid Platform | Background: Human cortical organoids offer powerful models of neurodevelopment, yet high-throughput screening (HTS) applications remain constrained by lengthy and inconsistent diseased cell lines; and irregular tissue boundaries and cortical layering in arrayed formats. Furthermore, existing perturbation approaches rely on non-specific small molecules or labor-intensive CRISPR editing. To overcome these limits, we developed a non-integrating nucleic acid delivery framework within an arrayed cortical organoids format to engineer tissue boundaries, establish functional benchmarks, and enable transient transcriptomic control. Methods & Results: Lipid nanoparticle (LNP)-mediated synthetic mRNA delivery demonstrated predictable dose-response kinetics that peaked at ~100 ng, revealing a saturation limit likely dictated by tissue surface accessibility. mRNA delivery maintained consistent peripheral localization with ~85% of transfected cells restricted to the outermost 50 µm without disrupting the stereotyped single neural rosette emergence (SNRE). This spatial confinement provides a reliable strategy to engineer boundary-defining populations to prevent neurite bridging and cellular emigration between arrayed organoids. To evaluate transcriptomic knockdown, an H9-SOX2-GFP reporter line was treated with phosphorothioate-backbone, universal and gapmer 2-MOE modified ASOs; a 24-hour incubation produced no significant reduction in GFP fluorescence, prompting ongoing testing with extended incubation times and LNP encapsulation. Conclusions: Together, peripheral mRNA delivery and characterization of ASO parameters establish a versatile bioengineering platform for arrayed cortical organoids. This approach combines high-throughput reproducibility with enhanced structural biomimicry, paving the way for scalable, spatially directed functional genomics. |
| 37 | Yuda Liu | Sushmita Roy | Modeling branching biological dynamics with tree-structured dynamic latent Dirichlet allocation | Probabilistic topic models, such as Latent Dirichlet Allocation (LDA), have emerged as powerful models to uncover interpretable latent representations from high-dimensional sparse measurements of biological processes, such as single-cell omics data as well as genome-scale gene regulatory networks (GRNs). These approaches have been used to define gene programs from Perturb-seq datasets, define cell clusters from scATAC-seq datasets, and identify shared and cell type-specific subnetworks for dynamic GRNs. However, LDA is inherently limited in capturing dynamics of a biological process such as differentiation or onset of disease. While existing dynamic topic models allow topics to evolve over time, they assume that the process changes along a single linear trajectory, which is unsuitable for modeling branching structure, commonly seen in developmental processes. To address this limitation, we developed DTMtree, a dynamic topic model that allows topics to change along linear and branching trajectories and that can be applied to a collection of scRNA-seq matrices as well as to dynamically changing GRNs. We applied DTMtree to a dynamic network for mouse reprogramming and a timecourse perturb-seq dataset. Our analysis identified more coherent topics than standard LDA, which captured unique and shared gene programs and subnetworks. Overall, DTMtree offers a broadly applicable approach for studying dynamic biological processes at the level of single-cell omic profiles and inferred networks. |
| 38 | Caterra Leavens | Jon Odorico | The Beta Cell “Invisibility” Cloak – Insights into Immune Recognition and β-Cell Stress | Introduction: Type 1 diabetes (T1D) is an autoimmune disease characterized by pancreatic β-cell destruction, resulting in insulin deficiency and hyperglycemia. Although pancreas and islet transplantation can restore glycemic control, lifelong immunosuppression limits widespread use. To overcome this, we developed a human embryonic stem cell (hESC) line lacking HLA Class I and II expression (double knockout, DKO) with doxycycline (DOX)-inducible CTLA4Ig (iC) and PD-L1 (iP). We hypothesize that DKO;iCP stem cell-derived islets (SCIs) evade innate and adaptive immune responses.
In addition, we are also exploring the immune-β-cell interface to better understand the root cause of T1D and identify key players involved in β-cell demise during an autoimmune attack. We hypothesize that T1D β-cells exhibit key differences in how they handle stress compared to non-diabetic β-cells. Methods: DKO;iCP hESCs, HUES8 (WT) hESCs, and T1D iPSCs were differentiated into SCIs. SCIs were co-cultured with human spleen-derived, T cell-enriched activated splenocytes (EAS) or isolated natural killer (NK) cells. Granzyme B secretion was measured by ELISA after 24-72 hours to assess immune-mediated cytotoxicity. Co-cultures were repeated using ER-stressed SCIs induced with 250-500 nM thapsigargin for 24-48 hours, depending on cell type. ER stress was confirmed by flow cytometry. Results: DKO;iCP, HUES8, and T1D SCIs displayed morphology comparable to cadaveric islets. DKO;iCP SCIs exhibited reduced autoreactive T-cell-mediated cytotoxicity compared with WT SCIs and reduced NK cell-mediated cytotoxicity compared with cadaveric islets. T1D-derived SCIs showed significantly greater T-cell-mediated cytotoxicity than ER-stressed WT SCIs, suggesting intrinsic disease-associated differences in β-cell state influence immune recognition and susceptibility to immune attack. Discussion: Gene-edited SCIs reduce innate and adaptive immune-mediated cytotoxicity in vitro, while T1D-derived SCIs display enhanced immune susceptibility independent of engineered immune-evasive strategies. These findings improve our understanding of β-cell–immune interactions and support development of next-generation cell replacement therapies for T1D. |
| 39 | Deep Kapadia | Jon Odorico | Improving Vascularization of Islets in Polyethylene Glycol (PEG) Scaffolds Using Pericytes | Type 1 diabetes (T1D) is an autoimmune disease that results in β-cell loss. While cadaveric islet transplantation offers a promising β cell replacement therapy, the islet isolation process severs vascular connections and disrupts interactions with supporting mural cells, including pericytes, that regulate microvascular stability and support β cell survival. The resulting loss of vascular and cellular support contributes to islet death and poor engraftment following transplantation. Recreating the islet vascular niche is an important strategy to improve islet engraftment and long-term survival. To address this challenge, we generated 3D islet-vascularized engineered organoids (IVEO) composed of primary human islets, endothelial cells (ECs), and N3ICD-induced pericyte-like cells (PCs), embedded within a polyethylene glycol (PEG) hydrogel (IVEO+PC). We hypothesized that combining endothelial and mural cell lineages would improve vascularization and maintain islet function compared with endothelial cells alone in vitro. IVEO+PC constructs were generated by embedding human pancreatic islets, GFP-expressing human umbilical vein endothelial cells (GFP-HUVECs), and pericytes (PC) within PEG hydrogels. After gelation, constructs were cultured with angiogenic growth factors and monitored for the formation of a vascular-like network. Constructs containing islets and ECs (IVEO), or ECs and PCs (EC + PC) served as comparison groups. Vascular-like network formation and PC localization were assessed by immunofluorescence. Networks were quantified from GFP epifluorescence images using AngioTool. Islet function was evaluated by static glucose-stimulated insulin secretion (GSIS) and measurement of secreted and intracellular human C-peptide by ELISA. IVEO+PC constructs exhibited the most extensive vascular-like networks, with increased vessel length, connectivity, and vessel area in vitro. These constructs also demonstrated higher C-peptide secretion across glucose-stimulation conditions and significantly greater intracellular C-peptide among all groups evaluated. These findings indicate that pericytes enhance EC-derived vascular-like network formation and may help preserve islet function within PEG-based organoids. |
| 40 | Rodsy Modhurima | Dawn Davis | Inhibiting G-alpha-Z-mediated Signaling Protects Beta Cell Identity and Slows Progression of Obesity-Induced Diabetes | In diabetic human donors, the Islets of Langerhans overexpress the Prostaglandin EP3 Receptor (EP3), an inhibitory G-Protein coupled receptor (GPCR). Ectopic elevation of EP3 signaling restricts cellular cAMP production and impinges on crucial signaling networks. In beta cells, overexpression of Gnaz, which couples to the EP3 receptor, limits insulin secretion and blunts the response to glucagon-like peptide receptor (GLP1) agonists. But the impact of pathological Gaz overexpression on overall islet function is not well understood.
To elucidate the role of inhibitory GPCR signaling in islet dysfunction and diabetes disease progression, we knocked out Gnaz in an obesity-induced diabetes mouse model (BTBR OB mice). We found that Gnaz-null OB mice are protected from hyperglycemia and have an increased capacity for insulin secretion. IF imaging of pancreas sections shows juvenile Gnaz-null mice OB mice have higher proliferation of beta cells compared to WT OB siblings. As a result, adult Gnaz-null OB mice have doubled percent beta cell area compared to WT OB and all lean littermates. Loss of Gnaz increases GLP1 synthesis and secretion. We observed that over 50% WT OB islets have abolished islet architecture and acinar infiltration–commonly observed in pre-diabetic and diabetic patients. Gnaz-null OB islets maintain regular architecture and exhibit minimal acinar infiltration. Ucn3 staining to evaluate whether abolished islet architecture is due to loss of beta cell maturity revealed that Ucn3 is co-expressed in only 30% of insulin-positive beta cells in WT OB mice and 50% of insulin-positive beta cells in Gnaz-null OB mice, indicating a partial rescue. Our findings highlight the key role that inhibitory G-proteins play in diabetes progression and reveal a therapeutic target to improve both endogenous GLP1 production and response to GLP1R signaling and increase the capacity for beta cell expansion and islet function. |
| 41 | Matthew Wagner | Barak Blum | Stromal and Neuronal Sources of Slit2/3 Ligands in the Adult Pancreas Exhibit Distinct Expression Patterns Independent of Robo2 Receptor Expression in the Islet | Pancreatic islets are clusters of endocrine cells that regulate blood glucose homeostasis. Although islet architecture is stable under homeostatic conditions, insulin resistance during obesity and prediabetes drives compensatory islet expansion to meet the increased glucoregulatory demand for insulin. In mice, islets are organized as a core of beta cells surrounded by a mantle of alpha and delta cells, with evidence suggesting that this cell-type arrangement is important for optimal, coordinated hormone release. The formation of islet architecture requires expression of Roundabout receptors 1 and 2 (Robo1/2) in endocrine cells and of Slits 2 and 3 (Slit2/3) from islet-extrinsic sources, proposed to originate from pancreatic mesenchyme. While Slit ligands are known to be present in the pancreas, the cellular sources and expression dynamics of Slit2/3 during islet expansion remain undefined. Here, we resolve Slit2/3 expression at the single-cell level in the adult murine pancreas and the Ob/Ob diabetic mouse model, and further examine the expression in human type 2 diabetes using single-cell RNAseq and histological analysis. We identify stromal populations, including fibroblasts and pericytes, as well as the neurons of intrapancreatic ganglia, as the dominant sources of Slit2/3. We further show that Slit3 expression is increased in Ob/Ob mice, and that SLIT2 expression is elevated in stromal cell populations of humans with type 2 diabetes. Together, these findings define the cellular origins and dynamic regulation of Slit2/3 during metabolic stress and support a potential role for Slit signaling in the diabetic islet microenvironment. |
| 43 | Vijay Mukesh Parmar | Sean Palecek | Developing Neurovascular Unit (NVU) organoids using engineered human pluripotent stem cell lines. | The neurovascular unit (NVU) is a highly integrated multicellular system of the central nervous system (CNS) that is composed of endothelial cells, pericytes, neurons, and glial populations such as astrocytes and microglia. Brain organoids derived from stem cells have emerged as powerful platforms for dissecting CNS developmental programs and for enabling high-throughput screening of therapeutics targeting neurological disorders. However, conventional organoid protocols are largely driven by exogenous modulation of various developmentally relevant signaling cues, primarily yielding organoids lacking vascular networks. This absence of coordinated angiogenesis and vasculogenesis restricts the ability to accurately recapitulate the in vivo developmental biology underlying proper NVU assembly, maturation, and ultimately, the establishment of a physiologically relevant blood-brain barrier (BBB). To overcome these limitations, we propose shifting from signaling cue-based differentiation toward a transcription-factor (TF)-driven strategy that enables the synchronous co-differentiation of multiple NVU cell types. By leveraging engineered doxycycline-inducible stem cell lines that transiently overexpress lineage-specifying TFs to rapidly generate highly pure populations of endothelial progenitor cells (EPCs), pericytes, and neural progenitor cells (NPCs), we have produced a naive NVU organoid containing all foundational NVU cell types within a unified 3D microenvironment. Upon subsequent maturation in defined media, this naive organoid is expected to progress through an in vivo-like developmental trajectory, ultimately establishing a robust NVU architecture containing mature NVU cell types. We will evaluate whether this approach yields a physiologically relevant BBB by examining the expression and localization of BBB-specific markers using immunofluorescence (IF) assay, followed by single-cell RNA sequencing at multiple stages of maturation to delineate the signaling pathways that drive the induction of BBB-associated gene expression. It is expected that this TF-driven strategy can provide a novel framework for modeling the NVU, enabling more faithful recapitulation of the in vivo developmental sequence that governs NVU assembly and BBB formation. |
| 44 | Jennifer Piciw | Anita Bhattacharyya | Human stem cell models reveal transcriptional and phenotypic consequences of Down Syndrome in neurogenesis | Down syndrome (trisomy 21, T21), the most common genetic cause of intellectual disability, is characterized by microcephaly. Altered proportions of neurons in the cortex at and before birth suggest that impaired prenatal neurogenesis is a key feature in Down syndrome. However, the mechanisms that lead to altered neurogenesis in Down syndrome are not well understood. During neurogenesis, neural progenitors are either maintained through proliferation or exit the cell cycle through asymmetric division to generate neurons. We tested the hypothesis that trisomy 21 alters neural progenitor dynamics resulting in premature exhaustion of progenitors. To identify shifts in the balance between progenitor cell proliferation and neuron differentiation in trisomy 21, we performed bulk RNA sequencing on isogenic trisomy 21 and control iPSCs at 10, 17, 21, 30 and 50 days into directed neural differentiation. Gene expression analysis suggests a reduction in proliferation in T21 combined with increased expression of key neuron maturation genes. Immunohistochemical analysis confirmed a reduced generation of DCX positive neurons from trisomy 21 iPSC derived neural progenitors across time, suggesting heterochronic development of neural progenitor in trisomy 21. Trisomy 21 neural progenitors show early markers of metabolic dysfunction and heterochronic expression of key pathways linked to neural fate including WNT and SHH. Ongoing work aims to align these results with heterochronic development in other progenitor populations, such as second heart field (SHF) cardiac progenitors. |
| 45 | Srishti Goswami | Raunak Sinha | Establishing Human Stem Cell Derived Retinal Organoids as a robust model to study blindness disorders and develop therapeutics | Establishing Human Stem Cell-Derived Retinal Organoids as a robust model to study blindness disorders and develop therapeutics:
Authors: Srishti Goswami1,2,3,4, Aindrila Saha2,3,4, Agustin Luz Madrigal1,3, Celia Bisbach1,3, Praveen Susaimanickam1,3, Yashdeep Phanse1,3, David Gamm1,3, Mrinalini Hoon1,2,3,4, Raunak Sinha1,2,3,4 1: Department of Ophthalmology and Visual Sciences, UW-Madison Human pluripotent stem cell (hPSC)-derived retinal organoids (ROs) represent a transformative advancement, offering a 3D system to recapitulate the complexity of the developing human retina. They serve as robust platforms for modelling inherited retinal diseases and testing therapies. The ability of RO photoreceptors to successfully relay sensory information depends on the formation of functional synapses to facilitate downstream signalling between photoreceptors and second-order neurons. Thus, validating the expression and function of photoreceptor synaptic proteins is critical. One family of synaptic proteins that facilitates neurotransmitter release from photoreceptor terminals are calcium channels but their physiological properties and expression profiles of these channels within RO photoreceptors remains unknown. This information is required as a key step for establishing ROs as authentic models of human retina. |
| 46 | Susmit Mhatre | Darcie Moore | A potential asymmetrically dividing vimentin expressing progenitor population in adult mouse hippocampus | Adult neural stem cells (NSC) are primarily quiescent and lose their ability to exit quiescence with aging and disease. We have previously found in vitro that the intermediate filament vimentin collapses around aggresome during quiescence exit to forming a vimentin cage. As the NSC divides, it asymmetrically segregates these cellular cargoes to one daughter cell, leading to a decrease in its proliferation rate while the other daughter remains able to rejuvenate the niche. In the absence of vimentin, NSCs have a reduced ability to exit quiescence. Although the role of vimentin in quiescence exit has been shown in vitro, its function in a physiological setting in vivo remains unknown. To study how vimentin is regulated in vivo, we developed a novel endogenous Vimentin-mScarlet reporter mouse line and crossed with Nestin-GFP. Single-cell RNA sequencing and prospective FACS isolation of distinct cell populations (mScarlet+ and/or GFP+ cells) revealed that Vimentin expression defines a downstream progenitor stage within the adult neurogenic niche. In primary and secondary sphere assays, Vim-mScar+ positive progenitors formed significantly smaller spheres and displayed reduced self-renewal compared to Nestin-GFP+ NSCs, which upregulate vimentin upon proliferation. Longitudinal single-cell timelapse imaging further revealed distinct division kinetics: while Nestin-GFP+ NSCs undergo predominantly symmetric divisions, Vim-mScar+ progenitors undergo asymmetric fate divisions. Differentiation assays following growth factor withdrawal showed that Vim-mScar+ progenitors exhibit significantly reduced neuronal potential and are strongly biased toward astrogliogenesis. We currently have establish capabilities for longitudinal live two-photon imaging paired with inducible lineage-tracing mouse lines, offering a robust platform to directly resolve these progenitor division kinetics and fate behaviors in vivo. Together, these findings potentially report vimentin as a key marker for an asymmetrically dividing glial progenitor population in the adult hippocampus, expanding our understanding of lineage commitment in adult neurogenesis. |
| 47 | Eli Cytrynbaum | Megan McClean | Role and regulation of cellular state transitions in Candida albicans commensalism and pathogenesis | Candida albicans is a prevalent, generally commensal member of the human mycobiome. Simultaneously, it is a major opportunistic pathogen with limited treatment options. Both C. albicans’ pathogenesis and commensalism are associated with a cycle of biofilm formation and dispersal, and its ability to invade a variety of host tissues while evading the immune system and treatment is partially due to its ability to switch between cellular states with distinct metabolic signatures, adhesins, and morphologies. Despite the importance of these transitions, dispersal–the process by which hyphal cells give rise to yeast-form cells–is poorly understood. Our work seeks to address this gap, proposing dispersal as a distinct, regulated step in the biofilm cycle resulting in a specialized cellular state primed for the dissemination of new biofilms. Using innovative high-throughput underoil microfluidic technology to assess over 30 clinical isolate strains spanning all major C. albicans clades, we have found that dispersal from biofilms occurs universally as a discrete event within biofilm development regulated by environmental cues and extracellular signaling. We further determine that dispersed cells are morphologically and functionally heterogenous, genetically diverse, and primed for the formation of new biofilm–exhibiting increased immune evasion, stress tolerance, fitness in competition with other microbes, and rapid adhesion and filamentation. Notably, we find dispersed cells represent a clinical priority with elevated epithelial damage, immunogenicity, and antifungal tolerance. By uncovering the regulatory pathways controlling dispersal and differential tolerances and susceptibilities of dispersed cells, our findings aim to reveal potential treatment targets to encourage commensalism over pathogenesis. |
| 48 | Freddy Caswell | Ken Poss | Cellular Plasticity During Zebrafish Scale Regeneration Under Altered Progenitor States | Zebrafish organs and scales exhibit remarkably robust regeneration, regrowing to the same state as the previously unharmed tissue. This process remains poorly understood, especially in scales, beyond the knowledge that progenitor cells give rise to de novo osteoblasts that eventually replace the torn scale. To better understand how these osteoblast progenitor cells adjust their behavior during regeneration, this project investigates the impact of p21 overexpression on scale growth during regeneration. p21 affects the cell cycle by inhibiting cell proliferation, thereby preventing osteoblasts from progressing through the full proliferative phase to build the new scale. This project reveals that cells instead exhibit cellular plasticity following overexpression, allowing the scale to regrow through adaptive processes. The p21 mutant showed a large difference in cell count, with the wildtype having over six times as many osteoblast cells. Despite this, mutant cells are sixty percent larger in volume and are still able to regenerate the same scale, compensating for the reduced cell number through other means. This was discovered using live imaging of scale regeneration over 130 hours, with transgenic reporters used to quantify changes in cell size, nuclear size, and tissue regrowth. This work provides a framework for understanding how regenerative programs in the genome buffer perturbations, with implications for developmental and regenerative medicine more broadly. |
| 49 | Amy Chen | Junsu Kang | Elucidating bone remodeling mechanisms in appendage regeneration using a novel zebrafish cliff mutant | Teleost fishes, such as zebrafish, and urodele amphibians possess the remarkable ability to regenerate entire amputated appendages, including fins and limbs, whereas this capacity in adult mammals is largely restricted to digit tips. Identifying the genes and molecular mechanisms that govern this process will advance our understanding of tissue regeneration. Through an unbiased forward genetic screen combined with a temperature-shift assay using adult zebrafish, we identified a mutant exhibiting defects in bone remodeling during fin regeneration. While control fins regenerate without bone fractures or callus formation, the mutant displays a high incidence of bone fractures and the presence of callus-like structure in regenerating fins. Based on this phenotype, we named the mutant cliff (Callus-Like Impairment in Fins with bone Fractures). Bone remodeling is maintained by the balanced activities of osteoblasts and osteoclasts. We therefore hypothesize that the cliff mutation disrupts the coordination between osteoblast-mediated bone deposition and osteoclast-mediated bone resorption. To test this, we will employ cellular and molecular approaches to characterize osteoblast and osteoclast populations and assess their functional activities during fin regeneration. In parallel, we will identify the causative gene through genetic mapping and subsequently elucidate the underlying cellular and molecular mechanisms. Together, these studies will provide mechanistic insight into how bone remodeling is precisely regulated to enable successful appendage regeneration. |
| 50 | Siyang Cao | Junsu Kang | Highly regenerative Tuft-like spike cells regulate resident macrophage population in zebrafish fin epidermis | Title: Highly regenerative Tuft-like spike cells regulate resident macrophage population in zebrafish fin epidermis
Specialized and functionally diverse epithelial cells mediate essential roles of epithelial tissues, including chemical sensing, immune cell interactions, and tissue homeostasis. However, the diverse specialized epithelial populations and their molecular signatures in the zebrafish fin epithelium remain poorly understood. Here, we integrated single-cell RNA sequencing (scRNA-seq) datasets encompassing uninjured and regenerating fins and identified specialized epithelial populations with distinct marker genes. Among them, we discovered a previously unrecognized tuft-like epithelial cell type marked by advillin (avil) expression. Using an avil reporter line, we uncovered the unique morphology and position of these cells: large epithelial cells projecting an apical, actin-enriched spike outward from the body – which we term spike cells. Notably, these avil+ spike cells exhibit close spatial association with a subset of mpeg1+ resident macrophages. During fin regeneration, these avil+ spike cells undergo dynamic changes in density, morphology, and orientation. Our data further suggest that these avil⁺ spike cells are primarily replenished through stem cell–mediated regeneration rather than self-renewal. As these cells mature, they progressively develop apical protrusions extending beyond the epithelial surface and expand their size from deeper epithelial layers toward the superficial epithelial layer, indicating a coordinated maturation process. Transcriptomic and pharmacological analyses revealed that spike cell regeneration depends on Alk signaling. Moreover, selective ablation of avil+ cells resulted in a marked reduction in macrophage abundance, suggesting a role of spike cells in maintaining the local immune cell population. Together, these findings establish a foundational framework for investigating tuft-like epithelial cell biology epithelial–immune interactions in zebrafish. |
| 51 | Steffani Manna | Junsu Kang | Reconstruction of the peripheral nervous system during fin regeneration | The ability to regenerate appendages varies widely across species. While adult mammals are largely restricted to digit tip regeneration, teleost fish and urodele amphibians possess the remarkable capacity to regenerate entire amputated appendages. A crucial requirement for successful appendage regeneration is the presence of nerves at the wound site, but how peripheral nerves robustly and precisely regenerate during appendage regeneration remain underexplored. Here, we utilize zebrafish fins to investigate how peripheral nerves are reconstructed during appendage regeneration. First, we define the neuroanatomy of fin tissues and identify two distinct peripheral nerve types based on their anatomical localization: epidermal and mesenchymal nerves. In uninjured fins, while epidermal nerves are present as singular fibers, mesenchymal nerves form bundled structures. These nerve bundles exhibit a distinct spatial organization, with no bundles detected at the center of the fin ray where endothelial cells are located. Instead, they are positioned beneath the osteoblast layer, suggesting a close association with osteoblasts. Following amputation, mesenchymal nerves initially extend broadly throughout the entire mesenchymal compartment, innervating both peripheral and inner regions. Notably, after the blastema fully forms, mesenchymal nerves become predominantly restricted to the peripheral blastema regions, where they realign with osteoblast progenitors, leaving the inner blastema largely devoid of neurons. Based on these observations, we hypothesize that osteoblasts and endothelial cells provide spatial cues to guide regenerating mesenchymal nerves during fin regeneration. To examine this, we will employ genetic ablation models to assess the roles of these cell populations in mesenchymal nerve regeneration. Identifying cellular and molecular guidance cues will provide critical insight into the mechanisms underlying peripheral nerve regeneration and its contribution to appendage regeneration. |
| 52 | Zihan Wang | Ken Poss | Investigating age-related loss of fin regeneration ability in Three-spined Stickleback | Regenerative ability often declines with age, in part due to limited cell turnover and gradual quiescence of developmental program. Therefore, indeterminate growers likely have more maintained regeneration capacity. While most teleost are indeterminate growers and regenerates fins life long, we unexpectedly find that three-spine sticklebacks (Gasterosteus aculeatus) cannot regenerate amputated fins as adults, and the loss happens within a 3-month window. We find that non-regenerative fish progress through stages of regeneration in a similar timeline as regenerative fish, but shows mis-guided bone matrix deposition and eventually fusion of hemi-rays. Through transcriptomic profiling, we identified a panel of molecular markers that might contribute to successful regeneration in younger fish. Together, these findings establish three-spined sticklebacks as a potentially powerful system for studying a rapid age-dependent transition from regenerative growth to maladaptive repair, and provide an opportunity to define the cellular and molecular requirements that determine whether an injured appendage successfully regenerates. |
| 53 | Everardo Anta | Tanja Dominko | The effect of pluripotency state asynchrony on the developmental potential of porcine complementation chimeras | Interspecies blastocyst complementation (IBC) utilizing human induced pluripotent stem cells (iPSCs) offers an alternative to current xenotransplantation strategies that rely on xenoantigen-edited pigs. By generating human iPSC-derived organs within organ-deficient pig embryos, IBC has the potential to produce chimeric organs with improved immunological compatibility. However, blastocyst-stage complementation with human iPSCs yields low chimerism, often below 2%, reflecting poor human donor cell survival and limited contribution to the developing embryo. We hypothesize that complementation at the 4-cell stage, coinciding with the onset of porcine embryonic genome activation (EGA), will provide a more permissive environment for synchronization of iPSC pluripotency state with that of the developing embryo, thereby enhancing human iPSC survival, integration, and lineage contribution. To establish parameters for future human-porcine chimeras, we characterized preimplantation integration dynamics of porcine iPSCs microinjected into EGA-stage parthenotes. We evaluated chimerism and viability via time-lapse imaging, nuclear staining, and TUNEL assays (n=44). iPSC proliferation positively correlated with host blastomere number (P = 0.005), and embryos reaching the blastocyst stage contained significantly more iPSCs than those undergoing developmental arrest (P < 0.05). Apoptosis rates were not different between iPSCs and host blastomeres (P = 0.75). These findings identified the EGA stage as a receptive and supportive environment for complementation and showed that donor cell persistence is linked to continued embryo development rather than donor cell viability alone. Although we used intraspecies complementation, the data indicate that asynchrony in pluripotency state (primed iPSCs are not outperformed by the totipotent/naïve state of embryonic blastomeres) does not affect iPSC or preimplantation embryo survival. Future complementation of ETV2-null host embryos with human iPSCs will investigate the feasibility of generating humanized, immunologically compatible vascular tissues for xenotransplantation. |
| 55 | Harshini Cormaty | Rupa Sridharan | Unraveling the Histone Demethylase Regulation of Primordial Germ Cell Specification | Unraveling the Histone Demethylase Regulation of Primordial Germ Cell Specification
During mouse embryonic development ~40 cells are designated as Primordial Germ Cells (PGCs) at embryonic day 7.5 (E7.5) and are destined to become sperm or egg. These cells undergo massive epigenetic reprogramming of repressive histone and DNA methylation, which is not seen in surrounding somatic cells. The repressive histone modification H3K9me2 is depleted immediately after PGC specification and lost globally by E9.5. H3K9me2 can be added by methyltransferases, G9a and GLP, and removed by demethylases, KDM3A and KDM3B. The global depletion of H3K9me2 has been attributed to the downregulation of the G9a and GLP. However, Kdm3a and Kdm3b remain highly expressed in the PGCs at E11.5 – long after their catalytic target is gone. Both KDM3A and KDM3B are vital for mouse spermatogenesis and KDM3B is also important for female fertility. Yet, their role in germ cell development before sex specification remains unknown. Therefore, I employ an in vitro differentiation model of embryonic stem cells to primordial germ cell like cells (PGCLCs) in which we can rapidly eliminate the KDM3 proteins using a “degron” tag. The PGCLC differentiation is a directed embryoid body differentiation in which ~20% of the cells are PGCLCs. Since PGCLC differentiation is heterogenous, we used single cell Multiome sequencing to tease out the gene expression and chromatin profiles between wildtype and degron PGCLCs and the surrounding niche of cells. Using these tools, we found that retention of H3K9me2, through complete removal of the KDM3 proteins, compromises PGCLC differentiation. |
| 56 | Morgan Brown | Rupa Sridharan | Investigating the Role of Blimp1 Dependence on KDM3A and KDM3B during Primordial Germ Cell Differentiation | Primordial germ cells (PGCs) are the precursors to sperm and egg cells. Bone morphogenic protein (BMP) signaling activates the three master transcription factors (TFs) that orchestrate PGC specification: Blimp1, Tfap2c, and Prdm14. These PGCs undergo massive epigenetic reprogramming, including loss of repressive histone 3 lysine 9 dimethylation (H3K9me2). This loss is exclusive to PGCs and not surrounding somatic cells. The loss of H3K9me2 has been attributed to downregulation of the enzymes that add this modification, G9a and GLP. However, the role of the enzymes that erase this modification, KDM3A and KDM3B, has remained unknown. PGC development can be modeled in a cell culture dish by differentiating embryonic stem cells (ESCs) into embryoid bodies, which contain various cell types resembling those in a mouse embryo, including PGC-like cells (PGCLCs). The loss of KDM3A and KDM3B, and thus retention of repressive H3K9me2, during this differentiation leads to a loss in ability to make PGCLCs, as seen by depletion of Blimp1 gene expression. Thus, we wonder if exogenous overexpression of Blimp1 in the absence of KDM3s will be able to rescue the differentiation of ESCs into PGCLCs. |
| 57 | Shuai Jia | Fei Zhao | Epithelial GATA2 promotes budding and stromal invasion of uterine glandular epithelium | Defects in uterine gland development and function are associated with recurrent implantation failure and an increased risk of pregnancy loss. Although uterine glands are essential for embryo survival, implantation, and placentation, the molecular mechanisms regulating uterine adenogenesis remain incompletely understood. During gland development in the postnatal uterus, glandular epithelium (GE) first differentiates from the luminal epithelium (LE) then buds and invades into the stroma, establishing tubular, coiled, and slightly branched glands that extend from the uterine lumen to the inner layer of the myometrium. GATA2, a member of the GATA family of transcription factors, is expressed in the LE, GE, and stroma of the postnatal uterus. To investigate the role of epithelial GATA2 in uterine gland development, we generated mice with epithelial-specific deletion of Gata2 using Pax8-Cre (Pax8-Cre;Gata2f/f, Gata2cKO). Despite normal uterine size and length at postnatal day 21 (PND21), Gata2cKO uteri completely lacked uterine glands. FOXA2 is a critical transcription factor required for GE differentiation and function and is normally expressed in the glandular epithelial cells that bud from the LE and extend into the stroma. Surprisingly, although Gata2cKO uteri lacked FOXA2+ glands in the stromal layer, FOXA2 expression was detected within the LE. These observations suggest that epithelial GATA2 is dispensable for FOXA2 expression and the generation of FOXA2+ epithelial cells but is required for the budding and stromal invasion of FOXA2+ epithelial cells. Because a critical epithelial population threshold is necessary for uterine gland development, we evaluated epithelial abundance in control and Gata2cKO uteri. At PND21, the total number of epithelial cells, the number of FOXA2+ epithelia, and the proportion of FOXA2+ epithelial cells were comparable, indicating that epithelial abundance and generation of FOXA2+ epithelial cells are not impaired in Gata2cKO uteri. Intriguingly, FOXA2+ epithelial cells in Gata2cKO uteri were clustered within the luminal epithelial layer and preferentially localized to the mesometrial side. Taken together, our results identify a novel epithelial-intrinsic role for GATA2 in promoting uterine gland budding and stromal invasion, uncovering a key regulator of a poorly understood step in uterine adenogenesis. |
